Focus area · independent systems-biology analysis
When hormonal transitions, gut symptoms and immune reactions overlap, the whole story matters.
Some women navigating hormonal transitions notice digestive, histamine, sleep or autonomic changes at the same time. The relationships are not always causal, and not always attributable to hormones — this analysis examines the competing explanations across the whole record, evidence-graded and with the uncertainties stated, for discussion with your licensed clinicians.
This is educational analysis, not a menopause clinic and not medical care. People of any gender with complex multisystem presentations are equally welcome — the same method applies.
Free written fit screen first · about 5 minutes · no files · no payment · written reply by email either way. The flagship engagement is $850, published before you apply.
Fit
Who this focus area is for — and who it is not.
A good fit when…
- You are in a hormonal transition — perimenopause, menopause, or a cycle-linked pattern — and your gut, immune or autonomic symptoms changed with it.
- You hold multiple lab reports (stool, hormonal, bile-acid, standard bloodwork) and no one has read them as one system.
- You want competing explanations graded by evidence strength, including the possibility that your symptoms are not one mechanism.
- You have licensed clinicians and want analysis prepared for discussion with them — not a replacement for them.
Not the right service when…
- You are looking for diagnosis, prescriptions, hormone therapy decisions, or medical supervision — that is your clinician's role, not this service.
- You want a single root cause guaranteed in advance. Complex cases often have more than one contributor, and the analysis says so when they do.
- You need urgent or emergency care. This is a slow, deliberate, written process.
- You want supplement protocols without clinician review. The intervention framework is built for your medical team to approve, modify or reject.
Where the overlap appears
Six patterns that commonly arrive together.
These patterns may co-occur in the same person — but co-occurrence is not proof of a shared cause. Each subsection states the candidate mechanisms and the alternatives that must be weighed against them.
Perimenopause and menopause transitions
What people commonly ask
- “Why did my digestion, sleep and reactivity all change in my forties?”
- “Why do my symptoms fluctuate with my cycle in a way they never used to?”
- “Is there a connection between the hormonal shift and the gut problems, or is it coincidence?”
Candidate mechanisms — and alternatives
Candidate pathways include declining ovarian hormone signalling altering gut motility, bile-acid handling, mast-cell threshold and vagal tone — but each of these also has independent causes, and the analysis treats the hormonal explanation as one hypothesis among several, not the default answer.
Relevant reading Why chronic illness can worsen in perimenopause
Progesterone, allopregnanolone and neurosteroid sensitivity
What people commonly ask
- “Why do I feel dramatically worse in the luteal phase of my cycle?”
- “Could progesterone or its metabolites be involved in my mood, sleep or reactivity?”
- “Is PMDD connected to my gut and immune symptoms, or are they separate problems?”
Candidate mechanisms — and alternatives
One candidate pathway involves allopregnanolone — a progesterone metabolite that modulates GABA-A receptors — and its interaction with mast-cell signalling. This is an active research question, not an established mechanism, and it is presented as a hypothesis to weigh against alternatives such as serotonin transport, iron status and thyroid function.
Relevant reading The sigma-1 receptor, allopregnanolone and mast-cell activation
Hormone-associated mast-cell and histamine reactivity
What people commonly ask
- “Why do my histamine reactions get worse at certain points in my cycle?”
- “Why did my food tolerances collapse around the same time my hormones shifted?”
- “Is this MCAS, histamine intolerance, or something else entirely?”
Candidate mechanisms — and alternatives
Estrogen can influence mast-cell degranulation thresholds and histamine metabolism, which is one candidate explanation for cycle-linked reactivity. Competing explanations — dysbiosis-driven histamine production, DAO activity, epithelial barrier state, medication effects — are graded alongside it rather than assumed away.
Relevant reading Estrogen, mast cells and cycle-linked gut symptoms · MCAS and histamine patterns · Why MCAS may not respond to standard treatment
Gut–liver, bile-acid and estrogen metabolism
What people commonly ask
- “Could my bile-acid metabolism be connected to both my gut symptoms and my hormonal picture?”
- “My stool test showed high beta-glucuronidase — does that prove estrogen recirculation is my problem?”
- “Why do fatty meals, reflux and hormonal flares seem to travel together?”
Candidate mechanisms — and alternatives
Bile acids, the gut microbiome and estrogen metabolism share real biochemical interfaces — microbial beta-glucuronidase can deconjugate estrogens, and bile-acid signalling touches motility and inflammation. But a stool marker is not proof of a hormonal mechanism: abundance is not flux, and a single enzyme measurement is not a diagnosis of estrogen excess. The analysis states what each result can and cannot support.
Relevant reading Bile acid dysfunction: the concept page · Bile acid ecology in chronic SIBO · Bile acid malabsorption, dysbiosis and gut dysfunction
Endometriosis, adenomyosis and reproductive–gut overlap
What people commonly ask
- “Why did my endometriosis symptoms return after surgery?”
- “Are my bowel symptoms part of the pelvic condition, or a separate gut problem?”
- “Could the gut microbiome be involved in estrogen recirculation relevant to my condition?”
Candidate mechanisms — and alternatives
Candidate pathways include the estrobolome (microbial modulation of estrogen recirculation), pelvic mast-cell infiltration, LPS-driven inflammation and iron-related oxidative stress. These are mechanistic hypotheses drawn from the literature — they do not replace gynaecological care, and the analysis is written to be discussed with the clinicians managing the condition.
Relevant reading Why endometriosis can recur after surgery
POTS, dysautonomia and post-viral autonomic patterns
What people commonly ask
- “Why did my heart rate, digestion and heat tolerance all change after an infection?”
- “Is my POTS connected to my gut symptoms and my hormonal cycle?”
- “Why do I react to foods, medications and standing up in the same week?”
Candidate mechanisms — and alternatives
Autonomic dysfunction, mast-cell reactivity and gut dysmotility are sometimes reported together — as in hEDS, POTS and MCAS — but evidence for a single unifying mechanism is limited, and each requires its own appropriate clinical evaluation. The analysis reconstructs the chronology and tests which mechanism best explains the sequence, including the possibility that they are parallel problems.
Relevant reading What may be driving POTS · hEDS, POTS and MCAS overlap · Why long COVID may not resolve
How I investigate a complex pattern
The same disciplined sequence, whatever the presentation.
- 01
Chronology and exposures first
When each symptom appeared, what changed around it — hormonal shifts, infections, medications, surgeries, dietary changes — before any mechanism is proposed.
- 02
Your existing results, read in context
Stool, bile-acid, hormonal and standard laboratory results are interpreted where they are relevant — and set aside where they are not. New testing is never ordered here.
- 03
Competing hypotheses, graded
Each candidate mechanism is stated with its evidence strength, the findings that support it, and the findings that argue against it. Alternative explanations stay visible.
- 04
A synthesis written for your clinicians
The written analysis and personalized intervention framework are prepared for review by your licensed medical team, with the uncertainties stated rather than hidden.
What stool and hormone testing can — and cannot — prove.
Many clients arrive with functional test results that have been over-interpreted elsewhere. Part of the analysis is stating plainly what each result actually supports.
- A stool test shows which microbes are present
- Microbe abundance is not metabolite flux — what organisms are doing matters more than which are detected, and most stool panels cannot measure activity.
- Fecal beta-glucuronidase is elevated
- This does not prove “estrogen dominance.” The enzyme is one step in a recirculation pathway, its measurement varies between labs, and the hormonal picture requires clinical interpretation.
- A hormone panel was abnormal on one day
- Hormones fluctuate across the cycle, the day and the hour. A single measurement is a data point, not a pattern — and perimenopause amplifies that variability.
- A bile-acid fraction was out of range
- A bile-acid fraction is not receptor activation. Bile-acid signalling depends on receptors, transporters and tissue context that a stool or serum fraction does not capture.
What the analysis delivers
A written reconstruction your clinicians can act on.
The engagement ends in a written mechanistic synthesis and a personalized intervention framework — prioritized targets, sequencing, and the questions to put to your medical team first. It does not diagnose, prescribe, or supervise treatment, and it does not promise that a hormonal explanation will be the one the evidence supports.
How this differs from a general menopause provider: BiomeLogic does not manage hormones or replace gynaecological or primary care. It provides an independent, integrative analytical synthesis for complex, overlapping cases — prepared so your licensed clinicians can make the decisions.
Start with fit — not payment
Does your pattern need to be read as one system?
Gate 1 is a free, short written fit screen. No files, laboratory reports, or payment are required. Every submission receives a written reply by email — including an honest “this is not the right service” when that is the answer.
Sessions are held remotely by video; Bowie, Maryland, United States.